TY  - GEN
AU  - Miyamoto,Brigitta E
AU  - Kakkis,Emil D
TI  - The potential investment impact of improved access to accelerated approval on the development of treatments for low prevalence rare diseases
SN  - 1750-1172
PY  - 2011///1121
KW  - Animals
KW  - Biomarkers
KW  - Biotechnology
KW  - economics
KW  - Clinical Trials as Topic
KW  - Drug Approval
KW  - legislation & jurisprudence
KW  - Humans
KW  - Orphan Drug Production
KW  - Outcome Assessment, Health Care
KW  - Rare Diseases
KW  - drug therapy
KW  - United States
KW  - United States Food and Drug Administration
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1186/1750-1172-6-49
ER  -